Extended-spectrum β-lactamase, carbapenemase and AmpC producing Enterobacteriaceae in companion animals

Veterinary Microbiology

Volumn 170, Issue 1-2, 2014, Pages 10-18

  Rubin, Joseph E ^a,b,c   Pitout, Johann D D ^b,c,d  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b CALGARY LABORATORY SERVICES   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antibiotic resistance; Companion animals; Enterobacteriaceae; Zoonoses; Lactamases

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE AMPC; CARBAPENEMASE; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; ENZYME ISOLATION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; REVIEW;

ANIMALIA; CANIS FAMILIARIS; ENTEROBACTERIACEAE; EQUIDAE; ESCHERICHIA COLI;

ANTIBIOTIC RESISTANCE; COMPANION ANIMALS; ENTEROBACTERIACEAE; ZOONOSES; Β-LACTAMASES;

ANIMALS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; PETS; ZOONOSES;

EID: 84896083634     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2014.01.017     Document Type: Review

References (78)

1. Albrechtova K., Dolejska M., Cizek A., Tausova D., Klimes J., Bebora L., Literak I. Dogs of nomadic pastoralists in northern Kenya are reservoirs of plasmid-mediated cephalosporin- and quinolone-resistant Escherichia coli, including pandemic clone B2-O25-ST131. Antimicrob. Agents Chemother. 2012, 56:4013-4017.
2. Bradford P.A., Urban C., Mariano N., Projan S.J., Rahal J.J., Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob. Agents Chemother. 1997, 41:563-569.
3. Bryskier, A., 2005. Penicillins. In: Bryskier, A. (Ed.) Antimicrobial Agents: Antibacterials and Antifungals. ASM Press, Washington D.C., pp. 113-162.
4. Canton R., Gonzalez-Alba J.M., Galan J.C. CTX-M enzymes: origin and diffusion. Front. Microbiol. 2012, 3:110.
5. Carattoli A., Lovari S., Franco A., Cordaro G., Di Matteo P., Battisti A. Extended-spectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome Italy, from 2001 to 2003. Antimicrob. Agents Chemother. 2005, 49:833-835.
6. Costa D., Poeta P., Brinas L., Saenz Y., Rodrigues J., Torres C. Detection of CTX-M-1 and TEM-52 beta-lactamases in Escherichia coli strains from healthy pets in Portugal. J. Antimicrob. Chemother. 2004, 54:960-961.
7. Dierikx C.M., van Duijkeren E., Schoormans A.H., van Essen-Zandbergen A., Veldman K., Kant A., Huijsdens X.W., van der Zwaluw K., Wagenaar J.A., Mevius D.J. Occurrence and characteristics of extended-spectrum-beta-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses. J. Antimicrob. Chemother. 2012, 67:1368-1374.
8. Dolejska M., Duskova E., Rybarikova J., Janoszowska D., Roubalova E., Dibdakova K., Maceckova G., Kohoutova L., Literak I., Smola J., Cizek A. Plasmids carrying blaCTX-M-1 and qnr genes in Escherichia coli isolates from an equine clinic and a horseback riding centre. J. Antimicrob. Chemother. 2011, 66:757-764.
9. Escobar Perez J.A., Olarte Escobar N.M., Castro-Cardozo B., Valderrama Marquez I.A., Garzon Aguilar M.I., Martinez de la Barrera L., Barrero Barreto E.R., Marquez-Ortiz R.A., Moncada Guayazan M.V., Vanegas Gomez N. Outbreak of NDM-1-producing Klebsiella pneumoniae in a neonatal unit in Colombia. Antimicrob. Agents Chemother. 2013, 57:1957-1960.
10. Ewers C., Bethe A., Semmler T., Guenther S., Wieler L.H. Extended-spectrum beta-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin. Microbiol. Infect. 2012, 18:646-655.
11. Ewers, C., Bethe, A., Stamm, I., Grobbel, M., Kopp, P.A., Guerra, B., Stubbe, M., Doi, Y., Zong, Z., Kola, A., Schaufler, K., Semmler, T., Fruth, A., Wieler, L.H., Guenther, S., in press. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence? J. Antimicrob. Chemother. doi:10.1093/jac/dkt516.
12. Ewers C., Bethe A., Wieler L.H., Guenther S., Stamm I., Kopp P.A., Grobbel M. Companion animals: a relevant source of extended-spectrum beta-lactamase-producing fluoroquinolone-resistant Citrobacter freundii. Int. J. Antimicrob. Agents 2011, 37:86-87.
13. Ewers C., Grobbel M., Stamm I., Kopp P.A., Diehl I., Semmler T., Fruth A., Beutlich J., Guerra B., Wieler L.H., Guenther S. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J. Antimicrob. Chemother. 2010, 65:651-660.
14. Fischer J., Rodriguez I., Schmoger S., Friese A., Roesler U., Helmuth R., Guerra B. Escherichia coli producing VIM-1 carbapenemase isolated on a pig farm. J. Antimicrob. Chemother. 2012, 67:1793-1795.
15. Gandolfi-Decristophoris P., Petrini O., Ruggeri-Bernardi N., Schelling E. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in healthy companion animals living in nursing homes and in the community. Am. J. Infect. Control 2013, 41(9):831-835.
16. Haenni M., Ponsin C., Metayer V., Medaille C., Madec J.Y. Veterinary hospital-acquired infections in pets with a ciprofloxacin-resistant CTX-M-15-producing Klebsiella pneumoniae ST15 clone. J. Antimicrob. Chemother. 2012, 67:770-771.
17. Hanson N.D. AmpC beta-lactamases: what do we need to know for the future?. J. Antimicrob. Chemother. 2003, 52:2-4.
18. Harada K., Morimoto E., Kataoka Y., Takahashi T. Clonal spread of antimicrobial-resistant Escherichia coli isolates among pups in two kennels. Acta Vet. Scand. 2011, 53:11.
19. Hordijk J., Schoormans A., Kwakernaak M., Duim B., Broens E., Dierikx C., Mevius D., Wagenaar J.A. High prevalence of fecal carriage of extended spectrum beta-lactamase/AmpC-producing Enterobacteriaceae in cats and dogs. Front. Microbiol. 2013, 4:242.
20. Huber H., Zweifel C., Wittenbrink M.M., Stephan R. ESBL-producing uropathogenic Escherichia coli isolated from dogs and cats in Switzerland. Vet. Microbiol. 2013, 162:992-996.
21. Hughes L.A., Pinchbeck G., Callaby R., Dawson S., Clegg P., Williams N. Antimicrobial prescribing practice in UK equine veterinary practice. Equine Vet. J. 2013, 45:141-147.
22. Huijbers P.M., de Kraker M., Graat E.A., van Hoek A.H., van Santen M.G., de Jong M.C., van Duijkeren E., de Greeff S.C. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in humans living in municipalities with high and low broiler density. Clin. Microbiol. Infect. 2013, 19:E256-E259.
23. Jacoby, G., Bush, K., 2014. B-lactamase classification and amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes (Lahey Clinic).
24. Jacoby, G.A., 2009, AmpC beta-lactamases. Clin. Microbiol. Rev. 22, 161-182 (Table of Contents).
25. Jacoby, G.A., Bush, K. 2013. Beta-lactamase classification and amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes.
26. Jacoby G.A., Munoz-Price L.S. The new beta-lactamases. N. Engl. J. Med. 2005, 352:380-391.
27. Johnson A.P., Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. J. Med. Microbiol. 2013, 62:499-513.
28. Johnson J.R., Clabots C., Kuskowski M.A. Multiple-host sharing, long-term persistence, and virulence of Escherichia coli clones from human and animal household members. J. Clin. Microbiol. 2008, 46:4078-4082.
29. Johnson J.R., Johnston B., Clabots C.R., Kuskowski M.A., Roberts E., DebRoy C. Virulence genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from humans, dogs, and cats. J. Clin. Microbiol. 2008, 46:417-422.
30. Lee J.H., Bae I.K., Lee S.H. New definitions of extended-spectrum beta-lactamase conferring worldwide emerging antibiotic resistance. Med. Res. Rev. 2012, 32:216-232.
31. Lim S.K., Lee H.S., Nam H.M., Jung S.C., Bae Y.C. CTX-M-type beta-lactamase in Escherichia coli isolated from sick animals in Korea. Microb. Drug Resist. 2009, 15:139-142.
32. Livermore D.M. Defining an extended-spectrum beta-lactamase. Clin. Microbiol. Infect. 2008, 14(Suppl. 1):3-10.
33. Livermore D.M., Woodford N. The beta-lactamase threat in Enterobacteriaceae Pseudomonas and Acinetobacter. Trends Microbiol. 2006, 14:413-420.
34. Ma J., Zeng Z., Chen Z., Xu X., Wang X., Deng Y., Lu D., Huang L., Zhang Y., Liu J., Wang M. High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals. Antimicrob. Agents Chemother. 2009, 53:519-524.
35. Matsumoto Y., Ikeda F., Kamimura T., Yokota Y., Mine Y. Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins. Antimicrob. Agents Chemother. 1988, 32:1243-1246.
36. Matthew M., Hedges R.W., Smith J.T. Types of beta-lactamase determined by plasmids in gram-negative bacteria. J. Bacteriol. 1979, 138:657-662.
37. Meyer E., Gastmeier P., Kola A., Schwab F. Pet animals and foreign travel are risk factors for colonisation with extended-spectrum beta-lactamase-producing Escherichia coli. Infection 2012, 40:685-687.
38. Murphy C., Reid-Smith R.J., Prescott J.F., Bonnett B.N., Poppe C., Boerlin P., Weese J.S., Janecko N., McEwen S.A. Occurrence of antimicrobial resistant bacteria in healthy dogs and cats presented to private veterinary hospitals in southern Ontario: a preliminary study. Can. Vet. J. 2009, 50:1047-1053.
39. Murphy C.P., Reid-Smith R.J., Boerlin P., Weese J.S., Prescott J.F., Janecko N., McEwen S.A. Out-patient antimicrobial drug use in dogs and cats for new disease events from community companion animal practices in Ontario. Can. Vet. J. 2012, 53:291-298.
40. Nam E.H., Ko S., Chae J.S., Hwang C.Y. Characterization and zoonotic potential of uropathogenic Escherichia coli isolated from dogs. J. Microbiol. Biotechnol. 2013, 23:422-429.
41. Nordmann P., Cuzon G., Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 2009, 9:228-236.
42. Nordmann P., Naas T., Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 2011, 17:1791-1798.
43. O'Keefe A., Hutton T.A., Schifferli D.M., Rankin S.C. First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States. Antimicrob. Agents Chemother. 2010, 54:3489-3492.
44. Paterson, D.L., 2006, Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control 34, S20-28 (discussion S64-73).
45. Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 2005, 18:657-686.
46. Peirano G., Pitout J.D. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 2010, 35:316-321.
47. Peirano G., Richardson D., Nigrin J., McGeer A., Loo V., Toye B., Alfa M., Pienaar C., Kibsey P., Pitout J.D. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada. Antimicrob. Agents Chemother. 2010, 54:1327-1330.
48. Peirano G., Sang J.H., Pitondo-Silva A., Laupland K.B., Pitout J.D. Molecular epidemiology of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae over a 10 year period in Calgary, Canada. J. Antimicrob. Chemother. 2012, 67:1114-1120.
49. Philippon A., Arlet G., Jacoby G.A. Plasmid-determined AmpC-type beta-lactamases. Antimicrob. Agents Chemother. 2002, 46:1-11.
50. Pitout J.D. Multiresistant Enterobacteriaceae: new threat of an old problem. Expert Rev. Anti Infect. Ther. 2008, 6:657-669.
51. Pitout J.D. Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment. Expert Rev. Anti Infect. Ther. 2012, 10:1165-1176.
52. Pitout J.D., Hossain A., Hanson N.D. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. J. Clin. Microbiol. 2004, 42:5715-5721.
53. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 2008, 8:159-166.
54. Platell J.L., Cobbold R.N., Johnson J.R., Heisig A., Heisig P., Clabots C., Kuskowski M.A., Trott D.J. Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob. Agents Chemother. 2011, 55:3782-3787.
55. Platell J.L., Cobbold R.N., Johnson J.R., Trott D.J. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J. Antimicrob. Chemother. 2010, 65:1936-1938.
56. Poirel L., Potron A., Nordmann P. OXA-48-like carbapenemases: the phantom menace. J. Antimicrob. Chemother. 2012, 67:1597-1606.
57. Rankin S.C., Whichard J.M., Joyce K., Stephens L., O'Shea K., Aceto H., Munro D.S., Benson C.E. Detection of a bla(SHV) extended-spectrum {beta}-lactamase in Salmonella enterica serovar Newport MDR-AmpC. J Clin Microbiol 2005, 43:5792-5793.
58. Rossolini G.M., D'Andrea M.M., Mugnaioli C. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin. Microbiol. Infect. 2008, 14(Suppl. 1):33-41.
59. Rubin J., Walker R.D., Blickenstaff K., Bodeis-Jones S., Zhao S. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections. Vet. Microbiol. 2008, 131:164-172.
60. Sallem R.B., Gharsa H., Slama K.B., Rojo-Bezares B., Estepa V., Porres-Osante N., Jouini A., Klibi N., Saenz Y., Boudabous A., Torres C. First detection of CTX-M-1 CMY-2, and QnrB19 resistance mechanisms in fecal Escherichia coli isolates from healthy pets in Tunisia. Vector Borne Zoonotic Dis. 2013, 13:98-102.
61. Schink A.K., Kadlec K., Schwarz S. Analysis of bla(CTX-M)-carrying plasmids from Escherichia coli isolates collected in the BfT-GermVet study. Appl. Environ. Microbiol. 2011, 77:7142-7146.
62. Shaheen, B.W., Nayak, R., Boothe, D.M., 2012. First reported case of New Delhi Metallo (NDM) carbapenem-positive gene in Escherichia coli from companion animals in the United States. In: 52nd ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, United States, September 9-12, 2012.
63. Shaheen B.W., Nayak R., Boothe D.M. Emergence of a New Delhi metallo-beta-lactamase (NDM-1)-encoding gene in clinical Escherichia coli isolates recovered from companion animals in the United States. Antimicrob. Agents Chemother. 2013, 57:2902-2903.
64. Shaheen B.W., Nayak R., Foley S.L., Kweon O., Deck J., Park M., Rafii F., Boothe D.M. Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States. Antimicrob. Agents Chemother. 2011, 55:5666-5675.
65. Sidjabat H.E., Hanson N.D., Smith-Moland E., Bell J.M., Gibson J.S., Filippich L.J., Trott D.J. Identification of plasmid-mediated extended-spectrum and AmpC beta-lactamases in Enterobacter spp. isolated from dogs. J. Med. Microbiol. 2007, 56:426-434.
66. Sidjabat H.E., Townsend K.M., Hanson N.D., Bell J.M., Stokes H.W., Gobius K.S., Moss S.M., Trott D.J. Identification of bla(CMY-7) and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia. J. Antimicrob. Chemother. 2006, 57:840-848.
67. So J.H., Kim J., Bae I.K., Jeong S.H., Kim S.H., Lim S.K., Park Y.H., Lee K. Dissemination of multidrug-resistant Escherichia coli in Korean veterinary hospitals. Diagn. Microbiol. Infect. Dis. 2012, 73:195-199.
68. Stolle I., Prenger-Berninghoff E., Stamm I., Scheufen S., Hassdenteufel E., Guenther S., Bethe A., Pfeifer Y., Ewers C. Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs. J. Antimicrob. Chemother. 2013, 68:2802-2808.
69. Tamang M.D., Nam H.M., Jang G.C., Kim S.R., Chae M.H., Jung S.C., Byun J.W., Park Y.H., Lim S.K. Molecular characterization of extended-spectrum-beta-lactamase-producing and plasmid-mediated AmpC beta-lactamase-producing Escherichia coli isolated from stray dogs in South Korea. Antimicrob. Agents Chemother. 2012, 56:2705-2712.
70. Timofte D., Dandrieux J., Wattret A., Fick J., Williams N.J. Detection of extended-spectrum-beta-lactamase-positive Escherichia coli in bile isolates from two dogs with bacterial cholangiohepatitis. J. Clin. Microbiol. 2011, 49:3411-3414.
71. Tzouvelekis L.S., Markogiannakis A., Psichogiou M., Tassios P.T., Daikos G.L. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev. 2012, 25:682-707.
72. van der Bij A.K., Pitout J.D. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J. Antimicrob. Chemother. 2012, 67:2090-2100.
73. Vo A.T., van Duijkeren E., Fluit A.C., Gaastra W. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses. Vet. Microbiol. 2007, 124:248-255.
74. Walsh T.R., Weeks J., Livermore D.M., Toleman M.A. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 2011, 11:355-362.
75. Wang Y., Wu C., Zhang Q., Qi J., Liu H., He T., Ma L., Lai J., Shen Z., Liu Y., Shen J. Identification of New Delhi metallo-beta-lactamase 1 in Acinetobacter lwoffii of food animal origin. PLoS ONE 2012, 7:e37152.
76. Wedley A.L., Maddox T.W., Westgarth C., Coyne K.P., Pinchbeck G.L., Williams N.J., Dawson S. Prevalence of antimicrobial-resistant Escherichia coli in dogs in a cross-sectional, community-based study. Vet. Rec. 2011, 168:354.
77. Woodford N., Turton J.F., Livermore D.M. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 2011, 35:736-755.
78. Yong D., Toleman M.A., Giske C.G., Cho H.S., Sundman K., Lee K., Walsh T.R. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 2009, 53:5046-5054.